Jian-guo Ma

No. 139 Ziqiang Road
Shijiazhuang, 050051, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

CKS2 promotes the malignant phenotypes of bladder cancer cells via PI3K/AKT signaling pathway activation.

CKS2 promotes the malignant phenotypes of bladder cancer cells via PI3K/AKT signaling pathway activation.

Journal: Cell cycle (Georgetown, Tex.)
Published: November 07, 2025

Beneficial effects of combined administration of Clopidogrel and Aspirin on the levels of proinflammatory cytokines, cardiac function, and prognosis in ST-segment elevation myocardial infarction: A comparative study.

Beneficial effects of combined administration of Clopidogrel and Aspirin on the levels of proinflammatory cytokines, cardiac function, and prognosis in ST-segment elevation myocardial infarction: A comparative study.

Journal: Medicine
Published: November 09, 2018

Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer.

Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer.

Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: October 14, 2017

Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients.

Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients.

Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: February 17, 2016

Efficacy and safety of Saw Palmetto Extract Capsules in the treatment of benign prostatic hyperplasia

Efficacy and safety of Saw Palmetto Extract Capsules in the treatment of benign prostatic hyperplasia

Journal: Zhonghua nan ke xue = National journal of andrology
Published: January 29, 2016

Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy.

Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy.

Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: December 20, 2015

Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer.

Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer.

Journal: Oncotarget
Published: December 04, 2015

Protocadherin17 Promoter Methylation is a Potential Predictive Biomarker in Clear Cell Renal Cell Carcinoma.

Protocadherin17 Promoter Methylation is a Potential Predictive Biomarker in Clear Cell Renal Cell Carcinoma.

Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: September 26, 2015

Promoter methylation of protocadherin8 is an independent prognostic factor for biochemical recurrence of early-stage prostate cancer.

Promoter methylation of protocadherin8 is an independent prognostic factor for biochemical recurrence of early-stage prostate cancer.

Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: December 09, 2014

Aberrant methylation of PCDH8 is a potential prognostic biomarker for patients with clear cell renal cell carcinoma.

Aberrant methylation of PCDH8 is a potential prognostic biomarker for patients with clear cell renal cell carcinoma.

Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: November 23, 2014

Aberrant methylation of CDH13 is a potential biomarker for predicting the recurrence and progression of non muscle invasive bladder cancer.

Aberrant methylation of CDH13 is a potential biomarker for predicting the recurrence and progression of non muscle invasive bladder cancer.

Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: September 09, 2014

Aberrant methylation of protocadherin 17 and its clinical significance in patients with prostate cancer after radical prostatectomy.

Aberrant methylation of protocadherin 17 and its clinical significance in patients with prostate cancer after radical prostatectomy.

Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: August 06, 2014
Showing 1-12 of 19

Last Updated: 09/26/2026